Tirzepatide produces average weight loss of 16% to 22.5% of body weight over 72 weeks in clinical trials
Personalized adjustments are often needed based on individual health status and goals
However, people with underlying conditions like a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), or severe gastrointestinal disease should avoid semaglutide injections and consult medical professionals at a weight loss clinic for alternative options
The side effect onset timeline varies, but most people who will experience GI symptoms feel them within the first 48 hours post-injection
Keep the vial in its original box or an opaque container to protect it from light exposure, which can degrade the peptide structure over time
For those who prefer hormonal birth control, its crucial to choose a method that can withstand possible changes in how hormones are absorbed or metabolized, especially since tirzepatide could alter hormone processing
